Jason Aryeh Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason Aryeh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason Aryeh. Jason Aryeh is Director in Aviragen Therapeutics, Inc. ($NABI).
Latest Insider Trading Transactions of Jason Aryeh
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2011 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | |
Mar 17 2011 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.87 | 4,900 | 28,763 | 131,783 | 136.7 K to 131.8 K (-3.58 %) |
Mar 16 2011 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.86 | 1,000 | 5,860 | 136,683 | 137.7 K to 136.7 K (-0.73 %) |
Mar 16 2011 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.82 | 2,400 | 13,968 | 137,683 | 140.1 K to 137.7 K (-1.71 %) |
Mar 15 2011 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.80 | 4,900 | 28,420 | 140,083 | 145 K to 140.1 K (-3.38 %) |
Mar 15 2011 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.75 | 9,900 | 56,925 | 144,983 | 154.9 K to 145 K (-6.39 %) |
Mar 15 2011 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.74 | 9,900 | 56,826 | 154,883 | 164.8 K to 154.9 K (-6.01 %) |
Dec 29 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.74 | 15,093 | 86,634 | 0 | 15.1 K to 0 (-100.00 %) |
Dec 17 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.74 | 1,907 | 10,946 | 179,876 | 181.8 K to 179.9 K (-1.05 %) |
Dec 10 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.49 | 4,705 | 25,830 | 181,783 | 186.5 K to 181.8 K (-2.52 %) |
Dec 03 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.53 | 6,700 | 37,051 | 186,488 | 193.2 K to 186.5 K (-3.47 %) |
Nov 22 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.25 | 2,832 | 14,868 | 193,188 | 196 K to 193.2 K (-1.44 %) |
Nov 22 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.25 | 463 | 2,431 | 196,020 | 196.5 K to 196 K (-0.24 %) |
Nov 22 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.24 | 4,900 | 25,676 | 196,483 | 201.4 K to 196.5 K (-2.43 %) |
Nov 15 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.30 | 4,900 | 25,970 | 201,383 | 206.3 K to 201.4 K (-2.38 %) |
Nov 12 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.39 | 11,200 | 60,402 | 206,283 | 217.5 K to 206.3 K (-5.15 %) |
Nov 12 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.26 | 6,400 | 33,677 | 217,483 | 223.9 K to 217.5 K (-2.86 %) |
Oct 20 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.01 | 8,553 | 42,851 | 223,883 | 232.4 K to 223.9 K (-3.68 %) |
Oct 20 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.00 | 12,020 | 60,100 | 232,436 | 244.5 K to 232.4 K (-4.92 %) |
Oct 13 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.00 | 4,422 | 22,110 | 244,456 | 248.9 K to 244.5 K (-1.78 %) |
Aug 19 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.74 | 600 | 3,446 | 248,878 | 249.5 K to 248.9 K (-0.24 %) |
Jun 15 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.74 | 2,147 | 12,324 | 249,478 | 251.6 K to 249.5 K (-0.85 %) |
Jun 07 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.81 | 258 | 1,499 | 251,625 | 251.9 K to 251.6 K (-0.10 %) |
May 25 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Option Exercise | A | 5.24 | 20,000 | 104,800 | 20,000 | |
Mar 26 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 6.24 | 234 | 1,460 | 251,883 | 252.1 K to 251.9 K (-0.09 %) |
Mar 26 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 6.25 | 64,793 | 404,833 | 252,117 | 316.9 K to 252.1 K (-20.45 %) |
Mar 24 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 6.24 | 28,510 | 177,902 | 316,910 | 345.4 K to 316.9 K (-8.25 %) |
Mar 23 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.99 | 7,800 | 46,722 | 345,420 | 353.2 K to 345.4 K (-2.21 %) |
Mar 22 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.97 | 200 | 1,194 | 352,620 | 352.8 K to 352.6 K (-0.06 %) |
Mar 22 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.96 | 6,381 | 38,031 | 352,820 | 359.2 K to 352.8 K (-1.78 %) |
Mar 19 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.96 | 2,619 | 15,609 | 359,201 | 361.8 K to 359.2 K (-0.72 %) |
Mar 19 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.94 | 8,800 | 52,272 | 361,820 | 370.6 K to 361.8 K (-2.37 %) |
Mar 17 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.93 | 200 | 1,186 | 370,620 | 370.8 K to 370.6 K (-0.05 %) |
Mar 16 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.93 | 16,000 | 94,816 | 370,820 | 386.8 K to 370.8 K (-4.14 %) |
Mar 16 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.93 | 600 | 3,558 | 386,820 | 387.4 K to 386.8 K (-0.15 %) |
Mar 15 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.88 | 180,700 | 1,062,335 | 387,420 | 568.1 K to 387.4 K (-31.81 %) |
Mar 12 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.74 | 16,100 | 92,414 | 568,120 | 584.2 K to 568.1 K (-2.76 %) |
Mar 10 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.75 | 3,200 | 18,393 | 584,220 | 587.4 K to 584.2 K (-0.54 %) |
Jan 15 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.49 | 13,800 | 75,774 | 587,420 | 601.2 K to 587.4 K (-2.30 %) |
Jan 14 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.49 | 86,200 | 473,367 | 601,220 | 687.4 K to 601.2 K (-12.54 %) |
Jan 08 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.29 | 46,157 | 244,171 | 687,420 | 733.6 K to 687.4 K (-6.29 %) |
Jan 08 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.29 | 3,443 | 18,213 | 733,577 | 737 K to 733.6 K (-0.47 %) |
Jan 08 2010 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.24 | 42,365 | 222,154 | 737,020 | 779.4 K to 737 K (-5.44 %) |
Dec 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.24 | 4,045 | 21,196 | 787,420 | 791.5 K to 787.4 K (-0.51 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.64 | 196 | 909 | 791,465 | 791.7 K to 791.5 K (-0.02 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.74 | 4,804 | 22,771 | 791,661 | 796.5 K to 791.7 K (-0.60 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.75 | 5,000 | 23,750 | 796,465 | 801.5 K to 796.5 K (-0.62 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.76 | 500 | 2,380 | 801,465 | 802 K to 801.5 K (-0.06 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.89 | 500 | 2,445 | 801,965 | 802.5 K to 802 K (-0.06 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.94 | 1,000 | 4,940 | 802,465 | 803.5 K to 802.5 K (-0.12 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.95 | 1,000 | 4,950 | 803,465 | 804.5 K to 803.5 K (-0.12 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.99 | 43,163 | 215,383 | 804,465 | 847.6 K to 804.5 K (-5.09 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.00 | 33,803 | 169,015 | 847,628 | 881.4 K to 847.6 K (-3.84 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.01 | 10,335 | 51,778 | 881,431 | 891.8 K to 881.4 K (-1.16 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.02 | 2,100 | 10,542 | 891,766 | 893.9 K to 891.8 K (-0.23 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.03 | 10,058 | 50,592 | 893,866 | 903.9 K to 893.9 K (-1.11 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.04 | 1,909 | 9,621 | 903,924 | 905.8 K to 903.9 K (-0.21 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.05 | 6,232 | 31,472 | 905,833 | 912.1 K to 905.8 K (-0.68 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.06 | 100 | 506 | 912,065 | 912.2 K to 912.1 K (-0.01 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.08 | 300 | 1,524 | 912,165 | 912.5 K to 912.2 K (-0.03 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.10 | 5,000 | 25,500 | 912,465 | 917.5 K to 912.5 K (-0.54 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.12 | 500 | 2,560 | 917,465 | 918 K to 917.5 K (-0.05 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.22 | 500 | 2,610 | 917,965 | 918.5 K to 918 K (-0.05 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.24 | 58,709 | 307,635 | 918,465 | 977.2 K to 918.5 K (-6.01 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 5.25 | 200 | 1,050 | 977,174 | 977.4 K to 977.2 K (-0.02 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.49 | 70,147 | 314,960 | 977,374 | 1 M to 977.4 K (-6.70 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.50 | 102,912 | 463,104 | 1,047,521 | 1.2 M to 1 M (-8.95 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.51 | 38,319 | 172,819 | 1,150,433 | 1.2 M to 1.2 M (-3.22 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.52 | 9,175 | 41,471 | 1,188,752 | 1.2 M to 1.2 M (-0.77 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.53 | 4,339 | 19,656 | 1,197,927 | 1.2 M to 1.2 M (-0.36 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.54 | 400 | 1,816 | 1,202,266 | 1.2 M to 1.2 M (-0.03 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.55 | 1,200 | 5,460 | 1,202,666 | 1.2 M to 1.2 M (-0.10 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.56 | 2,700 | 12,312 | 1,203,866 | 1.2 M to 1.2 M (-0.22 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.57 | 1,700 | 7,769 | 1,206,566 | 1.2 M to 1.2 M (-0.14 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.58 | 11,525 | 52,785 | 1,208,266 | 1.2 M to 1.2 M (-0.94 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.59 | 2,500 | 11,475 | 1,219,791 | 1.2 M to 1.2 M (-0.20 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.60 | 3,375 | 15,525 | 1,222,291 | 1.2 M to 1.2 M (-0.28 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.61 | 2,500 | 11,525 | 1,225,666 | 1.2 M to 1.2 M (-0.20 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.62 | 1,300 | 6,006 | 1,228,166 | 1.2 M to 1.2 M (-0.11 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.63 | 300 | 1,389 | 1,229,466 | 1.2 M to 1.2 M (-0.02 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Sell | S | 4.59 | 2,884 | 13,238 | 1,229,766 | 1.2 M to 1.2 M (-0.23 %) |
Nov 18 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Buy | W | 0.00 | 17,000 | 0 | 1,232,650 | 1.2 M to 1.2 M (+1.40 %) |
May 27 2009 | NABI | Aviragen Therapeut ... | Aryeh Jason | Director | Option Exercise | A | 2.66 | 20,000 | 53,200 | 20,000 |
Page: 1